Т1 mapping in the evaluation of the risk factors for diffuse myocardial fibrosis in essential arterial hypertension

Cover Page

Cite item


Background: The assessment of diffuse myocardial fibrosis is necessary to plan the management of patients with various cardiovascular disorders, including hypertensive heart disease. The development of imaging techniques has enabled a non-invasive detection of left ventricular myocardial fibrosis by magnetic resonance imaging (MRI) with T1 mapping.

Aim: By cardiac MRI, to identify risk factors for diffuse left ventricular myocardial fibrosis in patients with hypertensive heart disease.

Materials and methods: This was a cross-sectional observational study in 50 outpatients with hypertensive heart disease, aged 46 to 82 years (median, 68 [64; 72] years) and bodyweight of 52 to 120 kg (median, 91 [80; 98] kg). Standard cardiac MRI with delayed contrast enhancement was performed with Optima MR450w GEM 1.5T (General Electric, USA). For assessment of diffuse myocardial fibrosis MRI mapping by 2D MOLLI (3-3-5) technique was used. The results were analyzed with Cvi42 software (Circle Cardiovascular Imaging Inc., USA). The potential risk factors included patients’ age, gender, bodyweight, and diastolic heart failure.

Results: The mean time of T1 relaxation without contrast enhancement was 1122.64 ±63.67 ms, indicating the presence of myocardial fibrosis in 100% of the patients. Female patients had more advanced diffuse myocardial abnormalities (p < 0.001). In the elderly patients, there was a direct correlation between their age and degree of fibrosis (p = 0.006). There was an inverse correlation between higher bodyweight and increased extracellular volume. Heart rhythm disorders and diastolic heart failure had no impact on the changes in the mapping parameters of the left ventricular myocardium and MRI-assessed cardiac output values. No correlation between the myocardial fibrosis and dyslipidemia/hyperlipidemia was found. There was a direct correlation between the native T1 mapping values and extracellular volume fraction (p = 0.004) and an inverse correlation between low values of post-contrast T1 mapping and increased extracellular volume fraction (p = 0.05).

Conclusion: Т1 mapping in patients with essential arterial hypertension allows for detection of diffuse myocardial fibrosis of the left ventricle, which is recognised as a major indicator of myocardial remodeling. Female gender, older age, and bodyweight were the factors associated with more advanced myocardial fibrosis.

About the authors

A. S. Abramenko

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: a.s.abramenko@gmail.com
ORCID iD: 0000-0002-6286-2162

Alexander S. Abramenko - Research Fellow, Department of Radiology.

61/2-1 Shchepkina ul., Moscow, 129110, Tel.: +7 (495) 681 66 42

Russian Federation

M. V. Vishnyakova Jr.

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru
ORCID iD: 0000-0003-3838-636X

Marina V. Vishnyakova - MD, PhD, Head of Department of Radiology.

61/2 Shchepkina ul., Moscow, 129110

Russian Federation

M. V. Vishnyakova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru
ORCID iD: 0000-0002-2649-4198

Mariya V. Vishnyakova - MD, PhD, Chief of Chair of Radiology, Postgraduate Training Faculty.

61/2 Shchepkina ul., Moscow, 129110

Russian Federation

O. M. Drapkina

National Medical Research Center for Therapy and Preventive Medicine

Email: fake@neicon.ru
ORCID iD: 0000-0002-4453-8430

Oxana M. Drapkina - MD, PhD, Professor, Corr. Member of Russ. Acad. Sci., Director.

10-3 Petroverigskiy per., Moscow, 101990

Russian Federation

A. N. Kaburova

National Medical Research Center for Therapy and Preventive Medicine

Email: fake@neicon.ru
ORCID iD: 0000-0001-7717-1455

Anastasiya N. Kaburova - Junior Research Fellow, Department of Fundamental and Applied Aspects of Obesity.

10-3 Petroverigskiy per., Moscow, 101990

Russian Federation


  1. Российское кардиологическое общество. Артериальная гипертензия у взрослых: клинические рекомендации [Интернет]. 2020. 136 с. Доступно на: https://kuzdrav.ru/special/guideline/rko.php?EID=27493.
  2. Huttin O, Coiro S, Selton-Suty C, Juilliere Y, Donal E, Magne J, Sadoul N, Zannad F, Rossignol P, Girerd N. Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(12):e0168349. doi: 10.1371/journal.pone.0168349.
  3. Gonzalez A, Ravassa S, Lopez B, Moreno MU, Beaumont J, San Jose G, Querejeta R, Bayes-Geni's A, Diez J. Myocardial Remodeling in Hypertension. Hypertension. 2018;72(3):549-58. doi: 10.1161/HYPERTENSIONAHA.118.11125.
  4. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol. 2000;15(4):264-72. doi: 10.1097/00001573-200007000-00010.
  5. Chaturvedi RR, Herron T, Simmons R, Shore D, Kumar P, Sethia B, Chua F, Vassiliadis E, Kentish JC. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation. 2010;121(8):979-88. doi: 10.1161/CIRCULATIONAHA.109.850677.
  6. Bulluck H, Go YY, Crimi G, Ludman AJ, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Pica S, Raineri C, Sirker A, Herrey AS, Manisty C, Groves A, Moon JC, Hausenloy DJ. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19(1):26. doi: 10.1186/s12968-017-0343-9.
  7. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, Puntmann VO. Standardization of T1 measurements with MOLLI in differentiation between health and disease - the ConSept study. J Cardiovasc Magn Reson. 2013;15(1):78. doi: 10.1186/1532-429X-15-78.
  8. Reiter G, Reiter C, Krauter C, Fuchsjager M, Reiter U. Cardiac magnetic resonance T1 mapping. Part 1: Aspects of acquisition and evaluation. Eur J Radiol. 2018;109:223-34. doi: 10.1016/j.ejrad.2018.10.011.
  9. Radenkovic D, Weingartner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev. 2017;22(4):415-30. doi: 10.1007/s10741-017-9627-2.
  10. Бокерия ЛА, Бузиашвили ЮИ, Ключникова ИВ. Ишемическое ремоделирование левого желудочка (методологические аспекты, вопросы диагностики и лечения). М.: НЦССХ им. А.Н. Бакулева РАМН; 2002. 160 с.
  11. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108. doi: 10.1016/j.jcmg.2010.10.008.
  12. Rodgers CT, Robson MD. Cardiovascular magnetic resonance: physics and terminology. Prog Cardiovasc Dis. 2011;54(3):181-90. doi: 10.1016/j.pcad.2011.09.005.
  13. Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F, Raman SV. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging. 2009;2(6):437-43. doi: 10.1161/CIRCIMAG-ING.108.838367.
  14. MacKenna DA, Omens JH, McCulloch AD, Covell JW. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am J Physiol. 1994;266(3 Pt 2):H1007-18. doi: 10.1152/ajpheart.1994.266.3.H1007.
  15. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res. 2004;94(12):1533-42. doi: 10.1161/01.RES.0000129254.25507.d6.
  16. Muller-Brunotte R, Kahan T, Lopez B, Edner M, Gonzalez A, Diez J, Malmqvist K. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Hypertens. 2007;25(9):1958-66. doi: 10.1097/HJH.0b013e3282170ada.
  17. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305-13. doi: 10.1056/NEJ-Moa020245.
  18. Liu S, Liu CY, Han J, Turkbey EB, Liu YC, Bild D, Arai AE, McClelland R, Hundley WG, Gomes AS, Tracy R, Kronmal R, Lima JA, Bluemke DA. Relationship of diffuse myocardial fibrosis to body composition: the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Magn Reson. 2013;15 Suppl 1:O109. doi: 10.1186/1532-429X-15-S1-O109.
  19. Liu CY, Bluemke DA, Gerstenblith G, Zimmerman SL, Li J, Zhu H, Lai S, Lai H. Reference values of myocardial structure, function, and tissue composition by cardiac magnetic resonance in healthy African-Americans at 3T and their relations to serologic and cardiovascular risk factors. Am J Cardiol. 2014;114(5):789-95. doi: 10.1016/j.amjcard.2014.06.007.
  20. Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson. 2015;17(1):29. doi: 10.1186/s12968-015-0111-7.
  21. Rauhalammi SM, Mangion K, Barrientos PH, Carrick DJ, Clerfond G, McClure J, McComb C, Radjenovic A, Berry C. Native myocardial longitudinal (T1) relaxation time: Regional, age, and sex associations in the healthy adult heart. J Magn Reson Imaging. 2016;44(3):541-8. doi: 10.1002/jmri.25217.
  22. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-81. doi: 10.1093/aje/kwf113.

Supplementary files

There are no supplementary files to display.

Copyright (c) 2020 Abramenko A.S., Vishnyakova Jr. M.V., Vishnyakova M.V., Drapkina O.M., Kaburova A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies